SAXOL | Linksium
Back to portfolio

SAXOL

Incubation

A new therapeutic agent with dual properties: it synergises taxanes and protects against chemo-induced neuropathy

profilePhoto   Laurène El Bahhaj
Linksium Contact Laurène El Bahhaj +33 (0)7 76 23 29 19 laurene.elbahhaj@linksium.fr
Visuel SAXOL

Benefits

  • Reduction of taxane doses without loss of therapeutic efficacy
  • Reduced toxicity
  • Prevention of chemo-induced peripheral neuropathy

Key words

  • Taxane chemotherapy
  • Peripheral neuropathies
  • Cancer

Intellectual Property

  • 1 patent

Laboratory

  • IAB

Institutions

  • CNRS
  • INSERM
  • UGA

Linksium Continuum

  • Maturation
  • Incubation

Results

  • Available licenses

Context

Taxane-based chemotherapies are among the most frequently used cancer therapies. However, they have adverse effects such as neuropathy (CIPN), which have a major impact on patients' quality of life. These neuropathies are often the cause of treatment discontinuation and compromise the success of the cancer treatment. In 1 out of 4 cases, they may even persist irremediably.

Technology

SAXOL project is based on the discovery of Carba1, which acts in synergy with Taxol®, allowing doses to be reduced while maintaining its therapeutic effectiveness. It also activates a metabolic enzyme, which has a neuroprotective effect.

Advantages

  • Reduction of taxane doses for a preserved therapeutic effect: limitation of toxicities due to taxane formulations, reduction of resistance.
  • Neuroprotective effect preventing the onset of neuropathies for which there is no effective preventive treatment.

State of progress

  • Validated and patented method for the synthesis of Carba1
  • Synergistic effect of the Carba1/Taxol combination validated in vivo in a mouse tumour model
  • ADME-Tox: performed, no warning signals
  • Neuroprotection: demonstrated on neurons in vitro. Target and mechanism of action known.

Applications

  • Cancer chemotherapy
  • Prevention of chemo-induced peripheral neuropathy
  • Potential prevention of other neuropathies (diabetes) and neurodegenerative diseases